- Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG
- Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter 2023 and Full Year 2023
- Asensus Surgical, Inc. Schedules Fourth Quarter and Full Year 2023 Financial and Operating Results Conference Call for March 21, 2024
- Asensus Surgical to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
- Asensus Surgical Celebrates 1,000 Senhance Cases Completed at Three Global Hospitals
- Asensus Surgical Announces Nagoya University Hospital in Japan to Initiate Senhance Surgery Program
- Asensus Surgical Provides Preliminary 2023 Year-End Corporate Update
- Asensus Surgical Completes In Vivo Surgeon Lab for LUNA Surgical Robotic System
- Asensus Surgical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Asensus Announces Sale of Senhance Robotic System in Romania
More ▼
Key statistics
On Friday, Asensus Surgical Inc (ASXC:ASQ) closed at 0.241, 18.14% above the 52 week low of 0.204 set on Oct 30, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.24 |
---|---|
High | 0.248 |
Low | 0.2359 |
Bid | 0.2251 |
Offer | 0.270 |
Previous close | 0.241 |
Average volume | 1.30m |
---|---|
Shares outstanding | 271.99m |
Free float | 266.43m |
P/E (TTM) | -- |
Market cap | 65.55m USD |
EPS (TTM) | -0.3162 USD |
Data delayed at least 15 minutes, as of Apr 26 2024.
More ▼